Connection
Albert Kim to Disease Progression
This is a "connection" page, showing publications Albert Kim has written about Disease Progression.
|
|
Connection Strength |
|
 |
|
 |
|
0.403 |
|
|
|
-
Kim AE, Kang P, Bucelli RC, Ferguson CJ, Schmidt RE, Varadhachary AS, Day GS. Autoimmune Encephalitis With Multiple Autoantibodies: A Diagnostic and Therapeutic Challenge. Neurologist. 2018 Mar; 23(2):55-59.
Score: 0.372
-
Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, Wang N, Eichler AF, Chukwueke U, Forst DA, Arrillaga-Romany IC, Dietrich J, Corbin Z, Moliterno J, Baehring J, White M, Lou KW, Larson J, de Sauvage MA, Evancic K, Mora J, Nayyar N, Loeffler J, Oh K, Shih HA, Curry WT, Cahill DP, Barker FG, Gerstner ER, Santagata S. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022 03 14; 13(1):1325.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|